Lamotrigine Tablet
Product Images NDC 69102-639

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 69102-639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Owp Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bluestarterkit Owppharma

Pack label for LAMOTRIGINE Kit 25 mg tablets by OWP Pharmaceuticals, Inc. The label shows a Blue Starter Kit containing 35 tablets. Instructions indicate dosage schedules for weeks 1 to 5 with tablet counts and days outlined, including taking one 25 mg tablet every other day initially, progressing to two 25 mg tablets once daily by week 5. Storage information and a barcode are also visible.*

FDA Label Image

Graph1 Owppharma

A Kaplan-Meier survival curve chart comparing failure probability (%) on the Y-axis over time in weeks on the X-axis for Lamotrigine versus Placebo treatment. The chart includes censored data points marked by '+' symbols, showing lower failure probability for Lamotrigine compared to Placebo over the study period.*

FDA Label Image

Graph2 Owppharma

A Kaplan-Meier failure probability curve comparing Placebo and Lamotrigine treatment groups over 80 weeks. The y-axis represents failure probability (%) and the x-axis shows time in weeks. Curves for Placebo and Lamotrigine are displayed with censored data points marked.*

FDA Label Image

Greenstarterkit Owppharma

Packaging label for LAMOTRIGINE Kit, a human prescription drug by OWP Pharmaceuticals, Inc. The label describes a Green Starter Kit containing 25 mg and 100 mg tablets of lamotrigine, USP. It includes detailed dosage instructions over several weeks, with tablets imprinted to identify strength. Label also provides storage conditions and a barcode.*

FDA Label Image

Orangestarterkit Owppharma

LAMOTRIGINE Kit packaging label for tablets, USP, 25 mg strength by OWP Pharmaceuticals, Inc. The kit is labeled as the Orange Starter Kit and contains tablets with dosages of 25 mg and 100 mg. It includes dosing instructions for weeks 1 through 5 with a daily schedule for taking one 25 mg tablet per day initially, increasing to two 25 mg tablets per day, then transitioning to one 100 mg tablet per day. The label also includes storage instructions and a barcode.*

FDA Label Image

Shape Owppharma

Table showing the dimensional drawings of Lamotrigine tablets for 25 mg and 100 mg strengths, illustrating the upper and lower face designs of each tablet.*

FDA Label Image

Structure Owppharma

Chemical structure of lamotrigine, showing the molecular arrangement with chlorine atoms and nitrogen-containing rings consistent with the active ingredient lamotrigine.*

FDA Label Image

Torrent 2

FDA Label Image

Torrent Owppharma

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.